Search

everythinglearnresearchcommunity

for

Search:↓

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Scientists developed a new way to study mutations in a skin condition using blood cells, which may help diagnose and treat the disease.

Key genes and pathways involved in thyroid eye disease were identified, aiding potential treatment and diagnosis.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Using developmental signaling pathways could improve adult wound healing by mimicking scarless embryonic healing.

A new genetic mutation in the ODC1 gene causes developmental delay and other symptoms in a young girl.

LED light helps human hair root cells grow and move by activating certain cell pathways.

Prdm1 is necessary for early whisker development in mice but not for other hair, and its absence changes nerve and brain patterns related to whiskers.

A new method quickly detects hair changes from EGFR inhibitors using a microscope.

Hair loss in androgenic alopecia patients is linked to changes in certain genes that control cell growth and death.

Agouti protein affects melanocortin receptors through competitive antagonism and receptor down-regulation.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

CD44 signaling can help heal wounds without scars.

A new genetic mutation linked to CARASIL syndrome and small artery disease was found in a Chinese family.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

Digoxin is linked to a higher risk of anemia in patients with atrial fibrillation and heart failure.

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.

Enzymes called PADIs play a key role in hair growth and loss.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

Androgen receptor activity is influenced by hormones, co-factors, modifications, and mutations.

The research showed that CRISPR/Cas9 can fix mutations causing a skin disease in stem cells, which then improved skin grafts in mice, but more work on safety and efficiency is needed.

Adenine helps delay aging in human hair follicle cells.

Disrupting a specific protein's function in hair follicle stem cells triggers their activation and a self-healing process.

Removing REDD1 in mice increases skin fat by making fat cells larger and more numerous.

Two gene areas linked to male pattern baldness found, more research needed.

cp-asiAR may effectively treat androgenetic alopecia by promoting hair growth and reducing androgen receptor activity.